Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C006632 |
arsenic trioxide |
arsenic trioxide results in increased expression of PAX5 mRNA | increases expression | 20458559
|
D004958 |
Estradiol |
[Progesterone co-treated with Estradiol] results in increased expression of PAX5 mRNA | affects cotreatment|increases expression | 17404688
|
C051890 |
irinotecan |
irinotecan analog results in decreased expression of PAX5 mRNA | decreases expression | 18927307
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in decreased expression of and results in decreased activity of PAX5 protein | decreases activity|decreases expression | 14600275
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in decreased expression of PAX5 mRNA | decreases expression | 19675145 14600275
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in increased expression of PAX5 mRNA | increases expression | 18483191
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in increased expression of PAX5 mRNA alternative form | increases expression | 18483191
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in increased expression of PAX5 protein | increases expression | 18483191
|
D008070 |
Lipopolysaccharides |
Tetrachlorodibenzodioxin inhibits the reaction [Lipopolysaccharides results in decreased expression of and results in decreased activity of PAX5 protein] | decreases activity|decreases expression|decreases reaction | 14600275
|
D008070 |
Lipopolysaccharides |
Tetrachlorodibenzodioxin inhibits the reaction [Lipopolysaccharides results in decreased expression of PAX5 mRNA] | decreases expression|decreases reaction | 19675145 14600275
|
D008070 |
Lipopolysaccharides |
Tetrachlorodibenzodioxin inhibits the reaction [Lipopolysaccharides results in increased expression of PAX5 mRNA] | decreases reaction|increases expression | 18483191
|
D008070 |
Lipopolysaccharides |
Tetrachlorodibenzodioxin inhibits the reaction [Lipopolysaccharides results in increased expression of PAX5 mRNA alternative form] | decreases reaction|increases expression | 18483191
|
D008070 |
Lipopolysaccharides |
Tetrachlorodibenzodioxin inhibits the reaction [Lipopolysaccharides results in increased expression of PAX5 protein] | decreases reaction|increases expression | 18483191
|
D011374 |
Progesterone |
[Progesterone co-treated with Estradiol] results in increased expression of PAX5 mRNA | affects cotreatment|increases expression | 17404688
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin inhibits the reaction [Lipopolysaccharides results in decreased expression of and results in decreased activity of PAX5 protein] | decreases activity|decreases expression|decreases reaction | 14600275
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin inhibits the reaction [Lipopolysaccharides results in decreased expression of PAX5 mRNA] | decreases expression|decreases reaction | 19675145 14600275
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin inhibits the reaction [Lipopolysaccharides results in increased expression of PAX5 mRNA] | decreases reaction|increases expression | 18483191
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin inhibits the reaction [Lipopolysaccharides results in increased expression of PAX5 mRNA alternative form] | decreases reaction|increases expression | 18483191
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin inhibits the reaction [Lipopolysaccharides results in increased expression of PAX5 protein] | decreases reaction|increases expression | 18483191
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin inhibits the reaction [PRDM1 protein binds to PAX5 promoter] | affects binding|decreases reaction | 19237549
|
D014212 |
Tretinoin |
Tretinoin results in decreased expression of PAX5 mRNA | decreases expression | 16093312
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.24 | 14514962 15322242 11752688 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
4.33 | 11850527 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
4.58 | 11798837 19825857 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
4.58 | 11473722 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.77 | 16835633 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.84 | 15955085 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.21 | 11748828 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.23 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.31 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.41 | 16456186 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.73 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
17.05 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
17.05 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
17.05 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.23 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.93 | 15746008 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.78 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.62 | 15665606 15845082 15380490 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
1.97 | 17261762 16675129 12948864 18497071 19861407 17018787 17289903 14630087 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
1.97 | 17614352 15562024 16175315 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.97 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
1.97 | 16443354 16166294 16873071 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.99 | 16813970 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.63 | 11589617 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.86 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
3.02 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.60 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
4.80 | 14691202 15553829 16217749 11135700 15073043 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
4.80 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
4.80 | 1917145 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
5.32 | 19014326 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
4.38 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
2.35 | 16096774 16051514 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.50 | 16120746 18670907 18850075 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.24 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
2.95 | 18566989 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.99 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.41 | 16835633 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.60 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
6.09 | 16354765 15340226 8697196 12621046 15668235 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
6.09 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
4.06 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
irinotecan |
2.63 | 17287894 17725105 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
2.73 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
irinotecan |
2.73 | 16391804 18259882 17159606 17454858 18509181 16303861 15273666 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.31 | 17141729 14669216 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.51 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
3.89 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.89 | 10048152 15322242 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
3.89 | 9142499 10589399 9211117 17551590 14991402 9125849 16925845 9664655 9224671 8800419 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
4.40 | 15213294 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.72 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.66 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.85 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.59 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.96 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.65 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
13.47 | 15322242 16714409 18230668 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
13.47 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
4.11 | 17692515 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
7.98 | 11473722 18566989 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
7.98 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
9.82 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
9.82 | 10568697 9294722 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
4.79 | 15328337 17637181 15821434 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
2.36 | 12903497 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
9.52 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
9.52 | 16938888 9664655 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
3.57 | 15073043 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.81 | 11858732 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
4.28 | 9205823 11852909 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
9.84 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
9.84 | 17994277 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.59 | 16904648 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
3.17 | 17312396 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
5.04 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.36 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.60 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.97 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
6.97 | 9664655 14991402 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
4.65 | 16366002 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.62 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.25 | 12621046 15340226 16120746 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.48 | 15709030 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
4.19 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.49 | 8697196 16959395 15340226 16354765 18606429 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.43 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.93 | 16778211 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.99 | 18670907 18850075 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.76 | 15869954 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
9.13 | 17255318 12878042 17963957 17237260 9205823 |
MESH:D007249 |
Inflammation |
|
Progesterone |
9.13 | 15869954 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
9.13 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
3.13 | 16393666 16627594 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
4.12 | 17994277 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.93 | 17255318 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
10.89 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
10.89 | 15992940 17551590 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
2.72 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
3.21 | 15610895 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
6.75 | 15070760 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
6.75 | 17143497 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
4.08 | 17077332 12560223 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.70 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.63 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
10.43 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
10.43 | 16482212 19285840 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
4.02 | 16467208 20471514 16968895 19850784 17050201 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
4.02 | 17596541 16294345 19850784 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
8.20 | 19075265 12712474 11161223 16891316 12018890 16823087 16330433 11468182 17869043 16112521 15622746 17712046 16966277 19642359 19225113 9834237 16331271 17649720 15748426 19035177 12679006 17107899 15336539 15213294 17217047 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
8.20 | 16788101 16935935 17294898 16766008 17712046 19029980 17361223 17301526 19075265 17368321 9834237 15748426 17107899 19225113 19642359 12679006 19035177 17506722 16140955 16891316 16823087 17217047 17339181 17649720 16331271 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.68 | 16882451 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
5.09 | 15821434 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.50 | 9224671 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
5.18 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
5.18 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
5.18 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
5.18 | 18397230 16248980 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
4.73 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.73 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
6.34 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
6.34 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.56 | 15213294 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
4.36 | 21114838 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
2.36 | 19825857 11798837 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.36 | 19555203 11884234 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
6.62 | 17203775 11408345 16891317 11807958 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
6.62 | 11408345 17203775 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.93 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.87 | 17453147 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
1.97 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.78 | 16940565 |
MESH:D052016 |
Mucositis |
|
irinotecan |
5.40 | 17159606 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
3.29 | 19549372 14977855 11468182 15949261 19417148 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
5.12 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
7.87 | 16882451 16105982 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
7.87 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.24 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.49 | 16810080 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
4.29 | 16624393 |
MESH:D009362 |
Neoplasm Metastasis |
|
irinotecan |
3.26 | 18259882 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
2.52 | 16946489 16594593 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
4.13 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
18.34 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
18.34 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
18.34 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
7.87 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
7.87 | 9142499 |
MESH:D009447 |
Neuroblastoma |
|
irinotecan |
3.60 | 8761367 |
MESH:D017599 |
Neuroectodermal Tumors |
|
irinotecan |
5.12 | 8761367 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
11.90 | 12452020 19769630 16624393 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
11.90 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
11.90 | 17393432 16525653 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
11.90 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
3.13 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
5.57 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
5.57 | 15976015 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
4.47 | 19927285 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.69 | 12520081 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
4.95 | 12224865 11605937 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.89 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.59 | 11222880 11399792 11118676 11896295 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
4.17 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
3.16 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.16 | 16740699 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.91 | 16636307 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
5.19 | 16723453 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.90 | 10835634 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.17 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.40 | 16283617 16116481 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.93 | 18045962 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
4.29 | 16646077 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.94 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
5.94 | 16467112 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.68 | 15862959 16503802 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
3.56 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
irinotecan |
3.56 | 15723263 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
3.56 | 17261132 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
4.43 | 15821434 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.35 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
7.92 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
7.92 | 17045167 16026305 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
5.13 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
4.05 | 16051514 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
4.36 | 15213294 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.38 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
2.57 | 20435036 12973940 11780464 12845720 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.94 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
5.05 | 16752155 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
5.04 | 12125929 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.39 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.69 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.22 | 16287080 |